The fusion of BCR (located on chromosome 22q11.2) and ABL1 (located on chromosome 9q34) leads to chronic myeloid leukemia (CML) (Baccarani et al., 2019). This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.